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The genetic basis of the G, , gangliosidoses is complex. Three lysosomal polypeptides, encoded by three distinct genes, are essential for normal catabolism of the G,, ganglioside substrate in vivo: the a and /.3 subunits of P-hexosaminidase A (Hex A) and the G, , activator protein. Tay-Sachs disease (OMIM: 278200) and its variants, caused by deficiency of Hex A activity, results from mutations at the HEXA gene (15q23-q24), which encodes the a subunit of Hex A. Sandhoff disease (OMIM: 268800) and variants, characterized by combined deficiency of Hex A and Hex B activity, is caused by mutation in the HEXB gene (5q13) encoding the /3 subunit common to Hex A and Hex B. The AB variant of G, , gangliosidosis (OMIM: 272750) is caused by mutations in the GM2A gene (5q31.3-q33.1) encoding the G, , activator protein. In AB variant patients, Hex A and Hex B are structurally normal, and enzyme activities are in the normal range when measured in the presence of synthetic, hydrophilic substrates. However, hydrolysis of G, , ganglioside is impaired by absent or defective formation of the G, , ganglioside/GM2 activator/Hex A complex. All known variants of G, , gangliosidosis display autosomal recessive inheritance.
The clinical phenotypes associated with G,, gangliosidoses variants vary widely. They range from infantile-onset, rapidly progressive neurodegenerative disease culminating in death before age 4 years (classical Tay-Sachs and Sandhoff diseases and G, , activator deficiency) to late-onset, slowly progressive neurologic conditions compatible with long-term survival and with little or no effect on intellect.'-' Phenotypic variants of G,,, gangliosidosis have been classified according to age of the onset of symptoms into infantile, juvenile, and adult forms of the disease. However, these classifications are often arbitrary.
Recent advances in computer technology have created a new area of research and development "bioinformatics," which integrates biology and informatics. This area of study has provided invaluable information on newly discovered genes: localization of genes influencing complex phenotypes, molecular variation (mutations) influencing human diseases, and identification of functional DNA variants. These technological advances are likely to have a profound impact on current knowledge of complex disease etiology and may reveal novel approaches to disease treatment and prevention. Locusspecific mutation databases record genetic variation and are relevant to human genetic research, genetic epidemiology, and health care.
The exponential growth of information regarding allelic variation accounting for cause of and/or susceptibility to disease mandates the creation of a formal record of "mutation" at gene loci. The current pace of mutation discovery far exceeds the capacity to publish the data by conventional means. Databases provide the most efficient format to maintain an up-todate record of locus-specific allelic variation. A designated curator or curator consortium evaluates information. Curators receive and distribute information upon request.
The Human Genome Organization (HUGO) provides guidelines and recommendations for content and structure of mutation database^.^ These will provide the means to link locus-specific databases into a centralized human mutation database and to ensure cohesiveness in a community of users.
According to HUGO guidelines, niutation databases should be relational and have a minimum core of content in a shared
The core should include ( 1 ) a unique identifier for each allele, (2 a source/report for data, ( 3 ) a context for alleles (patient genotype or in vitro expression system used in stud-ies), and (4) a description of alleles. The allele description should be verified by a group or consortium. Relational databases enable users to perform queries on any aspect of the database content.
We report herein the establishment of three relational databases for the HEXA, HEXB, and GM2A genes accessed at the GM2 gangliosidoses home page (http://data.mch.mcgill.ca/ gm2-gangliosidoses/). HEXAdb (http://data. mch. mcgill.ca/ hexadb/), HEXBdb (http://data.mch.mcgill.ca/hexbdb/), and GM2Adb (http://data.mch.mcgill.ca/gm2a) are relational databases and are currently divided into four tables each: Mutation, Phenotype, Reference, and Association (Tables 1 and 2 Linux v5.1@ (Red Hat, Inc.) operating system. MySQL is a true multiuser, multithreaded SQL database server that enables one to access, store, and update information. The Web connection exists through a Perl DBI interface. Modifications and addtions to the databases are immediately undertaken by the curator using Microsoft Access 9 7 8 (Microsoft Corp.) through an ODBC (Open Database Connectivity) interface or directly using mySQL command scripts. The Perl scripts that make up the search engine were written in Wordpad 4.0@ (Microsoft Corp.) and then uploaded to the Debelle server (http://data.mch.mcgill.ca) using WS-FTP95 LE 4.60 (Ipswitch, Inc., 1992-1998). WS-FTP LE is a File Transfer Protocol (FTP) client application that can connect to any system that has a valid Internet address and contains an f l P server program, allowing one to transfer files between a wide variety of systems, includmg Windows, OS\2, and UNIX systems.
The Web pages were written in HTML 4.0 (Hyper Text Markup Language) programming code, by using a normal text editor, Wordpad 4.08 (Microsoft Corp.). HTML files were then uploaded to the Debelle server (http://data.mch.mcgill.ca) using WS-FTP95 LE 4.60 (Ipswitch, Inc., 1992-1998).
Logos and graphics for the Web pages were designed in Microsoft Powerpoint 9 7 8 (Microsoft Corp.) and then edited in Microsoft Photo Editor 3.08 (Microsoft Corp.).
RESULTS

Mutatii table
The Mutation table (see Table 1 ) provides specific molecular information on mutations identified. Each mutation has an ID G , gangliosidoses databases (identification number, the primary key), which is assigned by its order of entry, a systematic name (usually referring to the cDNA mutation), an alternative name (the corresponding codon change), as well as information on the nucleotide change (substitution, insertion, deletion), the mutation type (nonsense, missense, silent, abnormal splicing, frameshift), the nucleotide position, the region of the gene involved (exon, intron, UTR) and a description of mRNA and protein phenotypes. Also provided are information on the submitter, which refers to the investigator(s) who identified the mutation either in a peer reviewed publication or by direct submission. Citations of published articles are indicated.
The search engine also allows one to query the database in any of the listed fields. For example, Figure 1A illustrates the mutation data retrieval search page for HEXBdb. Figure 1B shows the output of a query on the "Mutation type" field for the value "frameshift" in the HEXB gene. The user can also select a table that displays mutation information for all the records in the database. The HEXA database records 100 mutations (51 missense, 19 abnormal splicing, 12 frameshifts, 8 nonsense, 6 deletions, and 4 silent mutations). HEXBdb records 25 mutations ( 10 missense, 6 frameshifts, 6 abnormal splicing, 1 nonsense, 1 deletion, and 1 silent) and GM2Adb records 5 mutations (2 missense, 2 frameshifts, and 1 nonsense).
Phenotype table
The Phenotype table (see Table 2 ) is designed to provide details on clinical and biochemical phenotype, age of onset, and genotype and ethnicity of patients harboring specific mutations. Each record in the Phenotype table has an associated mutation ID number. Also included in this table (where available) is a molecular diagnostic method used to detect the mutation. Abnormalities of enzyme properties or specific activity are also recorded.
The Phenotype table can be searched on any of these fields, and a complete table of phenotypes is available online. Figure  2A and B illustrate data retrieval following a search under "Clinical phenotype" for mutations leading to subacute HEXB (Sandhoff) variants. To date, clinical phenotypes are known for 88 of the 100 entries in HEXAdb. There are 56 acute, 15 subacute, and 7 chronic TSD variants. Three Hex A pseudodeficient alleles and seven benign alleles are also recorded. Twenty-four of 25 entries in HEXBdb are associated with known clinical phenotypes (15 acute, 4 subacute, 3 chronic, 1 asymptomatic, 1 benign). All five of the GM2Adb entries are associated with an acute phenotype.
Reference table
The Reference table provides a listing of articles reporting identification or analysis of specific mutations. In the case of published articles, the full reference to the article is specified as well as the PubMed ID, enabling the user to link to references containing the abstract in MEDLINE. The Reference table offers a search tool by author(s), journal, title, and year of publication.
A table with all references on record is available on the Web page. Currently 132 references are listed for HEXAdb, 32 for HEXBdb. and 7 for GM2Adb.
Association table
Finally, the Association (also called Resource) table links (i.e., relates) the main tables together and records the "submitter" who identified the mutation(s) either by publication or by personal submission.
Submission fonn
All three databases permit online submission of new mutations (see Fig. 3 ). The submitters are requested to provide data for all fields. The aim is to obtain as complete a record as possible, including clinical and biochemical data for each new submission. The submission form, which will permit a faster and more efficient means to regroup information, is directed to the curator, whose role it is to review the information and determine whether it is sufficient for inclusion.
The clinical descriptions requested in the submission form are limited to two categories, which lend themselves to standardization: age of onset and an index of severity with only six gradations. The criteria for application of these terms are found on the information page "Tay Sachs Disease, Gene Clinics, NIH." A direct link to this page is found at the top of the Phenotype Information section of the submission form. This form also contains a direct link to the email address of the curators, permitting the submitter to request assistance if necessary.
Additional clinical terms such as ataxic, dystonic, psychotic, muscle-wasting, etc., frequently appear in the clinical literature describing the presentation of nonclassical variants of these disorders. Submitters may wish to include this information in the "Comments" field. Terms used in this field are also available for search. 
Modeling of HEXA mutant alleles: genotype/phenotype correlations
To provide information concerning the effects of mutations on the manifestations of disease, a feature for viewing mapped positions of selected HEXA mutations onto the homologymodeled hexosaminidase structure was developed. The structural model of the Hex A a subunit was restricted to the catalytic domain (region of the protein containing a (pa), barrel motif, residues 160-487) of the wild-type protein. This is the region that has been modeled onto the template of the crystallized Serratia marcescens chit~biase.~ Theoretical models of HEXA rnissense mutations are being added to the Web page. 
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Currently, the 3D structures of the catalytic domains of both the human P-hexosaminidase a and P subunits can be viewed online, as can the localization of putative active site residues and some missense mutations (only for the a subunit). Preselected groups of residues at which mutations lead to similar clinical phenotypes or functional impairments (i.e., catalytic site) can be viewed or the viewer may place the arrow on a section of the protein backbone and left-click the mouse to find the amino acid name and position number displayed on the status line. Viewers may also select different rotational views of the protein and different modes of presentation of the peptide backbone. No theoretical models exist, as of yet, for the GM2 activator protein. Figure 4 illustrates the mapping of a subset of infantile acute and adult HEXA mutations onto the hexosaminidase model.
Mutations leading to acute TSD cluster at or near the active site. Adult mutations more often involve residues on the protein surface. It is important to note that not all mutations conform to these general principles. It is anticipated that correlation of new data on the biochemical phenotypes and structural localization of specific mutant residues may lead to the definition of new functional domains on the Hex A protein such as the activator binding or the dimerization regions.
a -
TSD screening mutation database development
This table will represent a collaborative effort and will include information regarding allele frequencies and numbers of alleles screened annually according to ethniclgeographic origin, number of affected fetuses identified by prenatal testing according to ethniclgeographic origin, screening tests for specific alleles, NTSAD-approved screening centers, etc. The planned format is illustrated in Figure 5 . Mutation data wdl be recorded separately for Ashkenazi Jews and other individuals. The form is intended for use by laboratories conducting community-based Tay Sachs carrier screening. Only those alleles known to be relatively frequent are listed. Information requested includes allele frequency data and ethnic origin of carriers. This information is expected to be useful in selecting appropriate diagnostic tests for local populationsIfamilies. The characterization of HEXA, HEXB, and GM2A gene mutations contributed to the understanding of the clinical heterogeneity of the GM2 gangliosidoses, the ethnic distribution of mutant alleles, and the structure-function relationships of the Hex isozyrnes. Information about HEXA, HEXB, and GM2A mutations has also provided for more accurate carrier detection, pre-and postnatal diagnosis, and prediction of outcome for affected individuals. The inclusion of this type of comprehensive information is only possible in databases which seek to provide in-depth characterization of one or a limited number of gene loci. These locus-specific databases can also include detailed information on diagnostic tests and ethnic distribution of alleles. By contrast, databases such as the Human Gene Mutation Database (HGMD) provide more limited informa- tion on all known human mutations and are useful to physicians or teachers who require only identification of a specific gene locus. HGMD is limited to five useful fields: codon, nucleotide change, amino acid change, name of associated disorder, and linkage to the abstract of a reference.
Mutations in the H E M gene
The majority of HEXA mutations cause complete loss of Hex A and lead to severe, infantile-onset neurodegenerative disease culminating in death by age 4. Later onset GM2 gangli- , 1s characterized by extreme variability of phenotype. This vari-I ation occurs within the patient population expressing the com-I mon G269S allele (variable expressivity) but also among pa-' tients expressing five other alleles leading to a late-onset ' (chronic) phenotype (heteroallelism). Knowledge of the frequency and distribution of these alleles should improve the efficacy of TSD carrier screening.
Ethnic distribution of TSD alleles
accounts for 20% of heterozygote alleles in non-Jewish European-derived populations. Carriers of TSD from other geographic isolates often harbor a specific subset of mutations even if the disease gene frequency is not elevated in the popu-
lation. An IVS 9 + 1 G>A mutation is the most frequent TSD allele in carriers of northern European origin,15 while in the Japanese population, 79% of mutant alleles result from a C178Y substitution not found in other populations.I6 The two pseudodeficiency mutations account for 36% of alleles in nonJewish Americans of European descent. 17 The remainder of TSD mutations are considered to be "rare" or "private."
Genotype/phenotype correlations
HEXA gene mutations associated with variant forms of TSD have been mapped onto a modeled structure of the catalytic domain of Hex A.9 Mutations leading to acute TSD were identified in two clusters: one located at or near the active site and including mutations associated with the B1 phenotype, the second cluster involving residues far from the active site which are associated with effects on enzyme stability and protein processing. Mutations leading to a less severe phenotype were also divided into two groups. Benign and adult mutations most often involved residues on the protein surface where a change does not exert a significant effect on protein stability. More severe late infantile and juvenile mutations affected residues which are located closer to the protein core. Not all phenotypes could be interpreted based on these general principles. Only five mutations have been documented in the GM2A gene encoding the G,, activator protein, and all patients have been homozygous for individual mutant alleles associated with complete absence of G, , ganglioside cleavage. The range of defects includes defective Hex A binding,'O-" enzyme instability," and degradation in the ER or Golgi.'"
Conclusion
The HEXAdb, HEXBdb, and GM2Adb online databases assist in regrouping scattered information into a centralized location that is easily accessible to the scientific community. The ability to submit new mutations online provides an efficient method for collecting and disseminating new information about these genes and their associated phenotypes. Protein modeling of individual mutations may also assist in developing a better understanding of genotypelphenotype correlations. The GM2 gangliosidoses databases and others like it serve the interests of genomics, human genetic diversity, medicine, and the needs of patients, families, and communities.
